These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2850749)

  • 1. Mode of action studies. Basis for the search of new antifungal drugs.
    Vanden Bossche H; Marichal P; Gorrens J; Geerts H; Janssen PA
    Ann N Y Acad Sci; 1988; 544():191-207. PubMed ID: 2850749
    [No Abstract]   [Full Text] [Related]  

  • 2. A new era in antimycotic agents.
    Rippon JW
    Arch Dermatol; 1986 Apr; 122(4):399-402. PubMed ID: 3006601
    [No Abstract]   [Full Text] [Related]  

  • 3. The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.
    Vanden Bossche H; Ausma J; Bohets H; Vermuyten K; Willemsens G; Marichal P; Meerpoel L; Odds F; Borgers M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3272-8. PubMed ID: 15328084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition and interaction of cytochrome P450 of Candida krusei with azole antifungal drugs.
    Venkateswarlu K; Denning DW; Kelly SL
    J Med Vet Mycol; 1997; 35(1):19-25. PubMed ID: 9061581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole activity against fungal germination.
    Strippoli V; Simonetti N; Retico A; Lucchetti G
    Drugs Exp Clin Res; 1988; 14(5):341-5. PubMed ID: 2851427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of ergosterol synthesis in Candida albicans by ketoconazole [proceedings].
    Van Den Bossche H; Willemsens G; Cools W; Cornelissen F
    Arch Int Physiol Biochim; 1979 Oct; 87(4):849-51. PubMed ID: 93943
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro investigations of Candida strains for itraconazole].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(1):23-7. PubMed ID: 2554367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents.
    Lamb DC; Kelly DE; Waterman MR; Stromstedt M; Rozman D; Kelly SL
    Yeast; 1999 Jun; 15(9):755-63. PubMed ID: 10398344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole.
    Ballard SA; Kelly SL; Ellis SW; Troke PF
    J Med Vet Mycol; 1990; 28(4):327-34. PubMed ID: 2176687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the susceptibility of Candida strains to ketoconazole and itraconazole in in vitro experiments].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(5-6):399-404. PubMed ID: 2561924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.
    Ryder NS; Frank I; Dupont MC
    Antimicrob Agents Chemother; 1986 May; 29(5):858-60. PubMed ID: 3524433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifolates as antimycotics? Connection between the folic acid cycle and the ergosterol biosynthesis pathway in Candida albicans.
    Navarro-Martínez MD; Cabezas-Herrera J; Rodríguez-López JN
    Int J Antimicrob Agents; 2006 Dec; 28(6):560-7. PubMed ID: 17046206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of anti-Candida drugs: focus on terconazole and other ergosterol biosynthesis inhibitors.
    Vanden Bossche H; Marichal P
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1193-9. PubMed ID: 1951574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antifungal agents on the adherence of Candida albicans to murine gastrointestinal mucosal surfaces.
    Mehentee JF; Hay RJ
    J Antimicrob Chemother; 1990 Jan; 25(1):111-9. PubMed ID: 2156790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.
    Fong IW; Bannatyne RM; Wong P
    Genitourin Med; 1993 Feb; 69(1):44-6. PubMed ID: 8383096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
    Ballard SA; Ellis SW; Kelly SL; Troke PF
    J Med Vet Mycol; 1990; 28(4):335-44. PubMed ID: 2176688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):580-7. PubMed ID: 1652656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.